š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The aim of this study is to evaluate the long-term persistence of hepatitis...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-11-01
Trial ID
NCT00289718
Treatments Being Tested
The aim of this study is to evaluate the long-term persistence of hepatitis...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-02-16
Trial ID
NCT00289744
Treatments Being Tested
The aim of this study is to evaluate the long-term persistence of hepatitis...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-11-01
Trial ID
NCT00289770
Treatments Being Tested
To evaluate the persistence of immune response 5 years and 6 years after th...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-09
Trial ID
NCT00197171
Treatments Being Tested
This study will evaluate the immune response against Hepatitis-A (HAV) and ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-05-01
Trial ID
NCT00875485
Treatments Being Tested
To evaluate the persistence of anti-hepatitis A virus (HAV) and anti-hepati...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-11-01
Trial ID
NCT00197184
Treatments Being Tested
This study will demonstrate the non-inferiority of GSK Biologicals' meningo...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-11
Trial ID
NCT00465816
Treatments Being Tested
To evaluate the persistence of anti-hepatitis A virus (anti-HAV) and anti-h...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-05
Trial ID
NCT00197119
Treatments Being Tested